104 related articles for article (PubMed ID: 2084925)
1. [Pathogenetic characteristics of hemostatic disorders in chronic renal failure].
Siatkovskiĭ VA; Pilotovich VS; Vasilenko LP; Zmachinskiĭ VA; Azarova LA; Shilaĭ LM
Ter Arkh; 1990; 62(12):59-62. PubMed ID: 2084925
[TBL] [Abstract][Full Text] [Related]
2. Hemostasis disorders in chronic renal failure.
Opatrný K
Kidney Int Suppl; 1997 Nov; 62():S87-9. PubMed ID: 9350690
[TBL] [Abstract][Full Text] [Related]
3. Successful kidney transplantation does not reverse the coagulopathy in patients with chronic renal failure on either hemo or peritoneal dialysis.
Ballow A; Gader AM; Huraib S; Mitwalli A; Al-Suleimani F; Al-Wakeel J
Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):177-85. PubMed ID: 17496391
[TBL] [Abstract][Full Text] [Related]
4. Platelet surface receptor activation in patients with chronic renal failure on hemodialysis, peritoneal dialysis and those with successful kidney transplantation.
Ballow A; Gader AM; Huraib S; Al-Husaini K; Mutwalli A; Al-Wakeel J
Platelets; 2005 Feb; 16(1):19-24. PubMed ID: 15763892
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of vitamin E metabolites in the blood of renal failure patients.
Galli F; Floridi AG; Floridi A; Buoncristiani U
Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960
[TBL] [Abstract][Full Text] [Related]
6. Platelet dysfunction and end-stage renal disease.
Kaw D; Malhotra D
Semin Dial; 2006; 19(4):317-22. PubMed ID: 16893410
[TBL] [Abstract][Full Text] [Related]
7. Haemostatic complications in haemodialysis patients: effect of type of vascular access and dialysis filter.
Yu A; Egberg N; Jacobson SH
Scand J Clin Lab Invest; 2003; 63(2):127-33. PubMed ID: 12751694
[TBL] [Abstract][Full Text] [Related]
8. [The effect of recombinant human erythropoietin during hemodialysis on the thrombocyte and erythrocyte functions of patients with chronic kidney failure].
Rud'ko IA; Balashova TS; Kubatiev AA; Ermolenko VM
Ter Arkh; 1994; 66(6):57-60. PubMed ID: 7940371
[TBL] [Abstract][Full Text] [Related]
9. [Disorders of hemostasis in chronic renal failure and renal transplantation].
Goluza E; Topalović MG; Hudolin T; Konosić S; Kocman IB; Perić M
Acta Med Croatica; 2011; 65(4):337-47. PubMed ID: 22359906
[TBL] [Abstract][Full Text] [Related]
10. [Fibrinolysis in chronic renal insufficiency treated wth periodic hemodialysis].
Triolo R; Cavagnino A; Cavalli PL
Minerva Med; 1972 Sep; 63(68):3704-12. PubMed ID: 5071959
[No Abstract] [Full Text] [Related]
11. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
12. [Arterial hypertension in patients on chronic hemodialysis].
Zogović J; Mladenović Lj
Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
[TBL] [Abstract][Full Text] [Related]
13. [Bleeding tendency in chronic kidney failure with hemodialysis].
Takahashi H; Shibata A
Nihon Rinsho; 1992 Jan; 50 Suppl():771-7. PubMed ID: 1578765
[No Abstract] [Full Text] [Related]
14. Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments.
Lucchi L; Bergamini S; Iannone A; Perrone S; Stipo L; Olmeda F; Caruso F; Tomasi A; Albertazzi A
Artif Organs; 2005 Jan; 29(1):67-72. PubMed ID: 15644086
[TBL] [Abstract][Full Text] [Related]
15. [The effect of hemodialysis on levels of beta-endorphin in serum of patients with chronic renal failure treated with erythropoietin].
Burak W; Grzeszczak W; Trelewicz P; Zukowska-Szczechowska E
Przegl Lek; 1996; 53(2):54-7. PubMed ID: 8754321
[TBL] [Abstract][Full Text] [Related]
16. Role of platelet factor 4-heparin complex antibody (HIT antibody) in the pathogenesis of thrombotic episodes in patients on hemodialysis.
Nakamoto H; Shimada Y; Kanno T; Wanaka K; Matsuo T; Suzuki H
Hemodial Int; 2005 Oct; 9 Suppl 1():S2-7. PubMed ID: 16223438
[TBL] [Abstract][Full Text] [Related]
17. [The anticoagulant activity of the plasma ultrafiltrate as a possible criterion of uremic poisoning].
Sukhanov VA; Chuzhinov SV; Koriakov IO; Zlokazov VB
Ter Arkh; 1991; 63(6):68-71. PubMed ID: 1948752
[No Abstract] [Full Text] [Related]
18. [Changes in platelets, coagulation and fibrinolysis in patients with chronic renal failure].
Terada H
Nihon Rinsho; 2004 Jun; 62 Suppl 6():147-52. PubMed ID: 15250284
[No Abstract] [Full Text] [Related]
19. Effect of blood purification on plasma levels of intact parathyroid hormone in patients with chronic renal failure.
Liu J; Liu ZQ; Tao HQ
Di Yi Jun Yi Da Xue Xue Bao; 2004 Feb; 24(2):234-5. PubMed ID: 14965840
[TBL] [Abstract][Full Text] [Related]
20. [Frequency and clinical implications of lupus anticoagulant in patients with terminal chronic renal failure in hemodialysis].
Fernández-Abreu MC; Diez-Ewald M; Briceño S; Torres-Guerra E; Rodríguez Z; Fernández N
Invest Clin; 2007 Mar; 48(1):69-79. PubMed ID: 17432545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
